Literature DB >> 33792930

A brief review of influenza virus infection.

Mostafa Javanian1, Mohammad Barary2, Sam Ghebrehewet3, Veerendra Koppolu4, VeneelaKrishnaRekha Vasigala5, Soheil Ebrahimpour1.   

Abstract

Influenza is an acute viral respiratory infection that affects all age groups and is associated with high mortality during pandemics, epidemics, and sporadic outbreaks. Nearly 10% of the world's population is affected by influenza annually, with about half a million deaths each year. Influenza vaccination is the most effective method for preventing influenza infection and its complications. The influenza vaccine's efficacy varies each season based on the circulating influenza strains and vaccine uptake rates. Currently, three antiviral drugs targeting the influenza virus surface glycoprotein neuraminidase are available for treatment and prophylaxis of disease. Given the significant burden of influenza infection globally, this review is focused on the latest findings in the etiology, epidemiology, transmission, clinical manifestation, diagnosis, prevention, and treatment of influenza.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  antiviral agents; epidemiology; influenza virus, treatment

Mesh:

Substances:

Year:  2021        PMID: 33792930     DOI: 10.1002/jmv.26990

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  14 in total

1.  Anti-Inflammatory Mechanisms of Total Flavonoids from Mosla scabra against Influenza A Virus-Induced Pneumonia by Integrating Network Pharmacology and Experimental Verification.

Authors:  Wei Cai; Shui-Li Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-08       Impact factor: 2.650

Review 2.  Emergence of SARS-CoV-2 Variants in the World: How Could This Happen?

Authors:  Alfredo Parra-Lucares; Paula Segura; Verónica Rojas; Catalina Pumarino; Gustavo Saint-Pierre; Luis Toro
Journal:  Life (Basel)       Date:  2022-01-28

3.  Trends in Influenza Infections in Three States of India from 2015-2021: Has There Been a Change during COVID-19 Pandemic?

Authors:  Anup Jayaram; Anitha Jagadesh; Ajay M V Kumar; Hayk Davtyan; Pruthu Thekkur; Victor J Del Rio Vilas; Shrawan Kumar Mandal; Robin Sudandiradas; Naren Babu; Prasad Varamballi; Ujwal Shetty; Chiranjay Mukhopadhyay
Journal:  Trop Med Infect Dis       Date:  2022-06-19

4.  Epidemiological and Clinical Characteristics of Influenza Outbreaks Among Children in Chongqing, China.

Authors:  Xuchen Meng; Han Zhao; Rong Ou; Qing Zeng; Huiqun Lv; Hua Zhu; Mengliang Ye
Journal:  Front Public Health       Date:  2022-04-15

5.  Protein Folding Interdiction Strategy for Therapeutic Drug Development in Viral Diseases: Ebola VP40 and Influenza A M1.

Authors:  Fernando Bergasa-Caceres; Herschel A Rabitz
Journal:  Int J Mol Sci       Date:  2022-03-31       Impact factor: 5.923

6.  Diversity and molecular network patterns of symptom phenotypes.

Authors:  Zixin Shu; Jingjing Wang; Hailong Sun; Ning Xu; Chenxia Lu; Runshun Zhang; Xiaodong Li; Baoyan Liu; Xuezhong Zhou
Journal:  NPJ Syst Biol Appl       Date:  2021-11-30

Review 7.  Isoquercetin as an Anti-Covid-19 Medication: A Potential to Realize.

Authors:  Majambu Mbikay; Michel Chrétien
Journal:  Front Pharmacol       Date:  2022-03-02       Impact factor: 5.810

8.  Design and Functional Analysis of Heterobifunctional Multivalent Phage Capsid Inhibitors Blocking the Entry of Influenza Virus.

Authors:  Lutz Adam; Eva Müller; Kai Ludwig; Simon Klenk; Daniel Lauster; Susanne Liese; Andreas Herrmann; Christian P R Hackenberger
Journal:  Bioconjug Chem       Date:  2022-06-27       Impact factor: 6.069

9.  The Efficacy of Aprotinin Combinations with Selected Antiviral Drugs in Mouse Models of Influenza Pneumonia and Coronavirus Infection Caused by SARS-CoV-2.

Authors:  Andrey A Ivashchenko; Bogdan A Zagribelnyy; Yan A Ivanenkov; Ilya A Ivashchenko; Ruben N Karapetian; Dmitry V Kravchenko; Nikolay P Savchuk; Elena V Yakubova; Alexandre V Ivachtchenko
Journal:  Molecules       Date:  2022-08-05       Impact factor: 4.927

10.  Inhibition of H1N1 Influenza Virus-induced Apoptosis by Ebselen Through ROS-mediated ATM/ATR Signaling Pathways.

Authors:  Danyang Chen; Ruilin Zheng; Jingyao Su; Jia Lai; Haitian Chen; Zhihui Ning; Xia Liu; Bing Zhu; Yinghua Li
Journal:  Biol Trace Elem Res       Date:  2022-07-27       Impact factor: 4.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.